The global plant derived proteins market will reach a valuation of US$ 185 Mn by 2029, witnessing a steady growth outlook during the forecast period (2019 – 2029). According to a new study by Future Market Insights (FMI), the market for plant derived proteins is largely influenced by tech transformations and R&D efforts towards recombinant proteins in the global healthcare industry.

“Rising demand for passive immunization has led to the development of new plant based platforms, which could transform and express recombinant therapeutic vaccines and antibodies more effectively with improved quality, yield, and stability,” reveals the FMI report.

Request report sample with 250+ pages to gain in-depth insights https://www.futuremarketinsights.com/reports/sample/rep-gb-11038

Key Research Findings of FMI’s Plant Derived Proteins Market Study

• Use of therapeutic plant based proteins in disease treatment will account for over 70% of overall market revenues in 2029.
• Transient plant expression systems continue as preferred plant sources among protein manufacturers with low-cost setups.
• Biopharmaceutical companies are primary end users of plant based proteins, holding 50% market share.
• Regenerative medicine -therapeutic agents continue to be a major application area, with a relatively cheap price point.
• North America remains the leading market; Asia Pacific turning highly lucrative.

Key Growth Drivers – Plant Derived Proteins Market

• Production and commercialization of biopharma proteins with better therapeutic results remain key growth drivers.
• Natural and eco-friendly attributes of plant based proteins would push their rate of consumption.
• Immunomodulatory characteristics of plant derived proteins are gaining traction in healthcare, fueling market growth.

Key Impediments – Plant Derived Proteins Market

• Stringent regulations regarding approval of plant based technology platforms restrict their commercialization.
• Regulatory restrictions on tobacco cultivation continue to limit growth opportunities in market.

Explore the complete plant derived proteins market report with 111 illustrative figures, 63 data tables, and the table of contents. Also find a detailed market segmentation on https://www.futuremarketinsights.com/reports/sample/rep-gb-11038

Competition Structure Analysis – Plant Derived Proteins Market

The competition landscape of plant derived proteins market remains moderately consolidated, with a major market share being accounted by Merck KGaA and Protalix Biotherapeutic. Key producers are also pushing for strategic acquisition of smaller regional businesses in the industry to expand their regional presence and bolster existing portfolios. This also involves exploring new sources of plant based proteins such as chia and hemp.

Some of the major players in the plant derived proteins market include, but are not limited to Cargill, Glanbia, ADM, Denka, Kentucky BioProcessing Inc. among others.